Genincode plc develops and commercializes genetic testing solutions aimed at assessing the risk of cardiovascular disease. The company offers a range of products, including genetic testing kits and laboratory testing services, which utilize genetic and clinical data to provide healthcare professionals with insights for patient risk assessment. Genincode operates primarily in the healthcare sector, serving hospitals, clinics, and healthcare providers, with a focus on markets in the United Kingdom and the United States.